Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
TJX Companies
TJX
|
+$984M |
| 2 |
Nike
NKE
|
+$866M |
| 3 |
Starbucks
SBUX
|
+$826M |
| 4 |
Qualcomm
QCOM
|
+$793M |
| 5 |
NXP Semiconductors
NXPI
|
+$786M |
Top Sells
| 1 |
Bank of America
BAC
|
+$2.04B |
| 2 |
Eli Lilly
LLY
|
+$1.23B |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$851M |
| 4 |
Procter & Gamble
PG
|
+$819M |
| 5 |
RTX Corp
RTX
|
+$803M |
Sector Composition
| 1 | Healthcare | 23.97% |
| 2 | Technology | 16.64% |
| 3 | Financials | 14.48% |
| 4 | Industrials | 10.53% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
iShares MSCI ACWI ETF
ACWI
$22.6B
| $20.7M | ﹤0.01% |
247,127
-475,592
| -66% | -$39.9M |
|
927
CubeSmart
CUBE
$9.49B
| $20.7M | ﹤0.01% |
+484,839
| New | +$20.7M |
|
928
Gentherm
THRM
$1.1B
| $20.6M | ﹤0.01% |
330,872
+202,154
| +157% | +$12.6M |
|
929
Mid Penn Bancorp
MPB
$694M
| $20.6M | ﹤0.01% |
765,245
-13,298
| -2% | -$359K |
|
|
HFSI
930
Hartford Strategic Income ETF
HFSI
$179M
| $20.6M | ﹤0.01% |
620,000
| – | – |
|
931
BHP
BHP
$138B
| $20.4M | ﹤0.01% |
363,808
-341,985
| -48% | -$19.2M |
|
932
Upwork
UPWK
$2.17B
| $20.4M | ﹤0.01% |
985,122
+263,203
| +36% | +$5.44M |
|
933
Gilead Sciences
GILD
$146B
| $20.3M | ﹤0.01% |
328,159
-401,336
| -55% | -$24.8M |
|
934
Ducommun
DCO
$1.39B
| $20.1M | ﹤0.01% |
468,009
+4,410
| +1% | +$190K |
|
935
Primis Financial Corp
FRST
$270M
| $20.1M | ﹤0.01% |
1,475,212
-21,158
| -1% | -$288K |
|
936
Huntsman Corp
HUN
$1.94B
| $20.1M | ﹤0.01% |
708,138
-173,027
| -20% | -$4.91M |
|
937
Evolent Health
EVH
$1.08B
| $20M | ﹤0.01% |
+652,518
| New | +$20M |
|
|
GMRE
938
Global Medical REIT
GMRE
$511M
| $20M | ﹤0.01% |
1,780,116
+258,804
| +17% | +$2.91M |
|
|
FORG
939
DELISTED
ForgeRock, Inc.
FORG
| $19.9M | ﹤0.01% |
927,356
-49,697
| -5% | -$1.06M |
|
940
Avanos Medical
AVNS
$576M
| $19.9M | ﹤0.01% |
726,039
+4,964
| +0.7% | +$136K |
|
941
Embotelladora Andina Series B
AKO.B
$3.85B
| $19.8M | ﹤0.01% |
1,785,027
+377,584
| +27% | +$4.2M |
|
942
3M
MMM
$84.9B
| $19.7M | ﹤0.01% |
182,225
+51,716
| +40% | +$5.6M |
|
943
argenx
ARGX
$46.7B
| $19.7M | ﹤0.01% |
51,985
-186,526
| -78% | -$70.7M |
|
944
Sabesp
SBS
$16.1B
| $19.7M | ﹤0.01% |
2,461,019
-628,948
| -20% | -$5.03M |
|
945
Vanguard Health Care ETF
VHT
$15.9B
| $19.5M | ﹤0.01% |
82,777
-82,423
| -50% | -$19.4M |
|
|
VERV
946
DELISTED
Verve Therapeutics
VERV
| $19.3M | ﹤0.01% |
1,263,384
-1,082,663
| -46% | -$16.5M |
|
947
Jack Henry & Associates
JKHY
$11.8B
| $19.3M | ﹤0.01% |
106,996
-330
| -0.3% | -$59.4K |
|
|
GBT
948
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $19.2M | ﹤0.01% |
601,981
+567,120
| +1,627% | +$18.1M |
|
|
FARO
949
DELISTED
Faro Technologies
FARO
| $19.2M | ﹤0.01% |
623,778
+162,018
| +35% | +$4.99M |
|
950
Entrada Therapeutics
TRDA
$203M
| $18.7M | ﹤0.01% |
1,535,883
-1,007,219
| -40% | -$12.3M |
|